NCT02270814View on ClinicalTrials.gov

Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 2, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Head and Neck CancerHead and Neck Squamous Cell CarcinomaCancer of the Head and Neck
Interventions
DRUG

nab-paclitaxel

DRUG

Cisplatin

DRUG

Carboplatin

BIOLOGICAL

Cetuximab

Trial Locations (5)

39216

University of Mississippi Medical Center, Jackson

57104

Sanford Cancer Center Oncology Clinic and Pharmacy, Sioux Falls

58122

Sanford Roger Maris Cancer Center, Fargo

63110

Washington University School of Medicine, St Louis

72205

University of Arkansas for Medical Sciences, Little Rock

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

Washington University School of Medicine

OTHER